butabarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Coadministration of CYP3A4 inducers may well reduce sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in clients which have made Actual physical dependence to sufentanil. Discont